CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

Stock Information for CDT Equity Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CDT Equity Inc.

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
CDT Equity Inc. Announces Reverse Stock Split
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
CDT Equity Announces Debt Update and New Loan Facility
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
CDT Announces Canadian Patent for AZD5904 in Male Infertility
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.